NCT02501421 Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine Status COMPLETED Phase PHASE1
NCT02497079 Diagnostic Accuracy of Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA Samples Status UNKNOWN Phase NA
NCT02454205 An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis Status COMPLETED Phase PHASE2/PHASE3
NCT02430506 A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB Status COMPLETED Phase PHASE1
NCT02430259 Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention Status COMPLETED Phase PHASE3
NCT02420444 A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults Status COMPLETED Phase PHASE1
NCT02415985 Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly Status COMPLETED Phase PHASE2
NCT02414828 A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB Status COMPLETED Phase PHASE2
NCT02413502 Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US Status COMPLETED Phase EARLY_PHASE1
NCT02412436 PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB Status COMPLETED Phase PHASE2
NCT02410772 TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens Status COMPLETED Phase PHASE3
NCT02393586 Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02391415 Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa Status COMPLETED Phase PHASE2
NCT02389322 Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65 Status COMPLETED Phase PHASE2
NCT02387242 Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers Status SUSPENDED Phase PHASE1
NCT02383849 IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants Status COMPLETED Phase N/A